LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates

EMBO J. 2023 Aug 15;42(16):e112414. doi: 10.15252/embj.2022112414. Epub 2023 Jun 29.

Abstract

The E3 ligase MDM2 promotes tumor growth and progression by inducing ubiquitin-mediated degradation of P53 and other tumor-suppressing proteins. Here, we identified an MDM2-interacting lncRNA NRON, which promotes tumor formation by suppressing both P53-dependent and independent pathways. NRON binds to MDM2 and MDMX (MDM4) via two different stem-loops, respectively, and induces their heterogenous dimerization, thereby enhancing the E3 ligase activity of MDM2 toward its tumor-suppressing substrates, including P53, RB1, and NFAT1. NRON knockdown dramatically inhibits tumor cell growth in vitro and in vivo. More importantly, NRON overexpression promotes oncogenic transformation by inducing anchorage-independent growth in vitro and facilitating tumor formation in immunocompromised mice. Clinically, NRON expression is significantly associated with poor clinical outcome in breast cancer patients. Together, our data uncover a pivotal role of lncRNA that induces malignant transformation of epithelial cells by inhibiting multiple tumor suppressor proteins.

Keywords: MDM2; NRON; long noncoding RNA; tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinogenesis / genetics
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic / genetics
  • Mice
  • Proto-Oncogene Proteins c-mdm2* / genetics
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • Ubiquitin-Protein Ligases / metabolism
  • Ubiquitination

Substances

  • Proto-Oncogene Proteins c-mdm2
  • RNA, Long Noncoding
  • Tumor Suppressor Protein p53
  • Ubiquitin-Protein Ligases
  • Mdm2 protein, mouse
  • NRON long non-coding RNA, mouse

Associated data

  • GEO/GSE226511